NIH microbicidal research spending will total $25 mil. in FY 1997, HHS' Shalala tells AIDS Conference.
NIH MICROBICIDE RESEARCH TO GET $25 MIL. IN FISCAL 1997 as part of an HIV prevention initiative announced July 9 by HHS Secretary Shalala at the XI International Conference on AIDS in Vancouver. "We are increasing our investment in research designed to prevent the transmission of HIV -- research into vaccines, into human behavior and into new forms of prevention," Shalala said. "As a central part of this strategy, we are stepping up our efforts to develop topical microbicides" under the auspices of the National Institutes of Health.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth